Clinical Trials
12 trialsNCT03933826 2026-05-12
CISTO
University of Washington
Active not recruiting
NCT04822350 2026-04-02
AVENANCE
Pfizer
Completed
NCT04053101 2025-09-18
TEP-Vessie
Institut Bergonié
Completed
NCT02756637 2023-08-07
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
Abramson Cancer Center at Penn Medicine
Completed
NCT03063125 2021-08-03
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
University of Kansas Medical Center
Completed
NCT01166230 2019-04-09
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
Photocure
Completed
NCT01637935 2018-03-07
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Takeda
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT02233842 2016-09-12
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
National Institutes of Health Clinical Center (CC)
Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT00634621 2014-08-25
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
GE Healthcare
Completed